Peptide record

TPDB43871

Antiviral standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43871
Antiviral
Anti-infective peptides
AI4AVP Peptipedia
standard
No
A 12-aa standard-residue antiviral peptide sequence curated from AI4AVP and Peptipedia, with an available 3D structural model.
Sequence
ADGTLLGRMKLA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C53H96N16O16S1
NCEQHIFPSWYV
L
1245.50
10.09
2
1
6
+1
0.76
0.292
114.17
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
2
A
1
R
0
N
1
D
0
C
0
E
0
Q
2
G
0
H
0
I
3
L
1
K
1
M
0
F
0
P
0
S
1
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 0 L: 3 K: 1 M: 1 F: 0 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 0
Chemical Descriptors
12 reviewed residue count
C53H96N16O16S1 sequence-only estimate (linear, free termini)
1245.50 sequence-only estimate (linear, free termini)
10.09 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
0.76 sequence-only estimate (linear, free termini)
0.292 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA